Böhm I, Träber F, Block W, Schild H
Universität Bonn.
Rofo. 2006 Mar;178(3):263-71. doi: 10.1055/s-2005-858791.
Soon molecular imaging techniques will play a prominent role in basic scientific research and clinical approaches. In particular, important aspects of medicine such as apoptosis and gene- and stem-cell therapy will play a pivotal role in radiology too. This review presents the basic principles of apoptosis, recent results and future perspectives of apoptosis imaging. Apoptosis or programmed cell death is a precisely regulated, complex cascade of molecular events to eliminate individual cells. Disturbances may lead to diseases like malignancies and neurodegenerative diseases that are of clinical relevance. Several therapeutic strategies in oncology are based on apoptosis induction; conversely, resistance to therapy is indicative of decreased apoptosis induction. Whereas up to now the clinician had to depend exclusively on biopsy specimens to detect apoptosis, the feasibility of non-invasive imaging of this cell-biological phenomenon in vivo opens up new horizons in future. This review focuses on different modifications of this imaging technique, with and without the use of molecular probes (e. g. annexin V, synaptotagmin I), in vitro and in vivo using the various detector systems (like MRI, flow cytometry) currently available. Future perspectives are also addressed.
不久之后,分子成像技术将在基础科学研究和临床应用中发挥重要作用。特别是,医学的重要方面,如细胞凋亡以及基因和干细胞治疗,在放射学中也将发挥关键作用。本综述介绍了细胞凋亡的基本原理、细胞凋亡成像的最新成果和未来展望。细胞凋亡或程序性细胞死亡是一种精确调控的、复杂的分子事件级联反应,用于清除单个细胞。干扰可能导致具有临床相关性的疾病,如恶性肿瘤和神经退行性疾病。肿瘤学中的几种治疗策略基于诱导细胞凋亡;相反,对治疗的抗性表明细胞凋亡诱导减少。到目前为止,临床医生不得不完全依赖活检标本检测细胞凋亡,而对这种细胞生物学现象进行体内无创成像的可行性为未来开辟了新的视野。本综述重点关注这种成像技术的不同改进,包括使用和不使用分子探针(如膜联蛋白V、突触结合蛋白I),以及在体外和体内使用目前可用的各种检测系统(如磁共振成像、流式细胞术)。还探讨了未来展望。